Fungal conjunctivitis is a rare clinical entity, primarily associated with species of the genus Candida. These organisms have the capacity to proliferate opportunistically following topical treatment with corticosteroids or broad-spectrum antibiotics. Other agents have been identified as potential etiological agents for conjunctivitis including Sporothrix, Aspergillus, Fusarium, and Microsporidia. Some species causing conjunctivitis are associated with systemic or immunosuppression-related infections; however, the majority of these species typically manifest as opportunistic infections, except Sporothrix. The diagnosis of fungal conjunctivitis is a diagnosis of exclusion, requiring a high level of clinical suspicion. Conventional microbiological studies are generally considered to be both sensitive and specific. Therapeutic modalities involve topical agents to systemic interventions. The prognosis for this condition is contingent on various factors, including whether it is considered an isolated conjunctival condition or if it is part of a systemic disease. The efficacy of treatment also depends on the patient’s immune status.